During the past decade, Woolcock Institute of Medical Research conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Woolcock Institute of Medical Research" #1 sponsor was "Woolcock Institute of Medical Research" with 3 trials, followed by "Elastagen Pty Ltd" with 2 trials sponsored, "McGill University" with 2 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored and "Fisher and Paykel Healthcare" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Woolcock Institute of Medical Research" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 2 trials as a collaborator, "University of Sydney" with 2 trials as a collaborator, "Azienda Ospedaliera S. Luigi, Orbassano (TO)" with 1 trials as a collaborator, "Baylor College of Medicine" with 1 trials as a collaborator and "Fondazione Salvatore Maugeri" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Woolcock Institute of Medical Research" are "Bronchiectasis" (2 trials), "Insomnia Disorder" (2 trials), "Latent Tuberculosis Infection" (2 trials), "COPD" (1 trials) and "Chronic Obstructive Pulmonary Disease" (1 trials). Many other conditions were trialed in "Woolcock Institute of Medical Research" in a lesser frequency.

Most popular intervention types in "Woolcock Institute of Medical Research" are "Drug" (9 trials), "Device" (3 trials), "Other" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Isoniazid" (2 trials), "Rifampin" (2 trials), "30 mg Cannabinol (CBN)" (1 trials) and "300 mg Cannabinol (CBN)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Woolcock Institute of Medical Research" are 15 trials for "All" genders.

Currently, there are NaN active trials in "Woolcock Institute of Medical Research". 1 are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Woolcock Institute of Medical Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Woolcock Institute of Medical Research, 4 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".